Week in Review: April 1-5

Living fossils not so fossilized; Canadian gov’t threatens scientists’ freedom to speak and publish; gene therapy for sensory disorders; an unusual theory of cancer; clues for an HIV vaccine

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Triops longicaudatusWIKIPEDIA, STEVE JURVETSONA handful of recent studies suggest that the term “living fossil” is inaccurate and misleading. Most recently, a genetic analysis of tadpole shrimp suggests that despite the animals’ strikingly similar appearance to their Triassic ancestors—with a shield-shaped body ending in a forked pair of filaments—they are, in fact, genetically quite distinct. Other examples of “living fossils” proven to be evolving at the same rate as, or even faster than, organisms that haven’t received the fallacious title include coelacanths, cycads, and tuataras, all of which were recently shown to differ significantly from their prehistoric relatives.

“I would favor retiring the term ‘living fossil’ altogether as it is generally misleading,” Africa Gomez at the University of Hull told The Scientist.

SCIENCEUNCENSORED.CAHeather Douglas, the Waterloo Chair in Science and Society in the Department of Philosophy at the University of Waterloo in Ontario, argues in this opinion piece that the Canadian government’s rules requiring government scientists to get approval before speaking to the media are impinging on the public’s freedom of information. Even worse, she says, scientists’ freedom to publish is being undermined. “Despite denials by officials, there is evidence that Canadian government scientists are being required to get approval before submitting papers for publication,” she writes—“and that approval is as much about political ideology as about evidential soundness.”

STOCK.XCHNG, DJEYEWATERAfter a long and sordid history, the gene therapy field has finally started to break its way into the clinic, with the first treatment approved in Europe last November. One area where the technique has been particularly successful is in treating blindness, with several therapies in clinical trials. But it turns out that gene therapy is also proving its worth in a variety of other sensory disorders, including deafness and anosmia, though these therapies are still being tested in animal models. Gene therapies for pain management, with the goal of avoiding opioid tolerance and dry mouth, have entered early-phase human trials.

Robert AustinROBERT AUSTINPrinceton University’s Robert Austin, who runs one of 12 physical science oncology centers launched by the National Institutes for Health in 2009, believes that cancer is a natural consequence of our rapid evolution and that the disease might act as a form of global population control, possibly serving to increase species fitness. The Scientist spoke with Austin about his unorthodox views, including his idea to maintain cancer by feeding tumors, rather than trying to eliminate it.

HIV virionsCDCTracking the evolution of a single HIV infection—and the resulting antibodies produced by the patient—researchers have uncovered clues about the development of broadly neutralizing antibodies, capable of blocking many strains of HIV but produced by only about 20 percent of HIV-positive people. The researchers hope that by understanding what antigens drive the development of these important antibodies, they can recreate the process in a vaccine that could be widely beneficial to all HIV patients.

Obama ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo
Unlocking the Unattainable in Gene Construction

Unlocking the Unattainable in Gene Construction

dna-script-primarylogo-digital
Concept illustration of acoustic waves and ripples.

Comparing Analytical Solutions for High-Throughput Drug Discovery

sciex

Products

Atelerix

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo
Singleron Avatar

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Logo

Zymo Research Launches Research Grant to Empower Mapping the RNome